S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
Log in
NASDAQ:ACAD

ACADIA Pharmaceuticals News Headlines

$48.98
+3.16 (+6.90 %)
(As of 03/5/2021 12:00 AM ET)
Add
Compare
Today's Range
$44.30
Now: $48.98
$49.25
50-Day Range
$45.82
MA: $50.56
$54.46
52-Week Range
$30.02
Now: $48.98
$58.72
Volume1.72 million shs
Average Volume941,023 shs
Market Capitalization$7.84 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.44

Headlines

ACADIA Pharmaceuticals (NASDAQ ACAD) News Headlines Today

Source:
SourceHeadline
ACADIA Pharmaceuticals (NASDAQ:ACAD) Rating Increased to C- at TheStreetACADIA Pharmaceuticals (NASDAQ:ACAD) Rating Increased to C- at TheStreet
marketbeat.com - February 26 at 7:08 AM
 Analysts Anticipate ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) to Announce -$0.60 EPS Analysts Anticipate ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) to Announce -$0.60 EPS
americanbankingnews.com - March 7 at 8:10 PM
ACADIA Pharmaceuticals (NASDAQ:ACAD) Stock Price Up 6.9%ACADIA Pharmaceuticals (NASDAQ:ACAD) Stock Price Up 6.9%
americanbankingnews.com - March 5 at 7:33 PM
ACADIA Pharmaceuticals (NASDAQ:ACAD) Price Target Increased to $65.00 by Analysts at Morgan StanleyACADIA Pharmaceuticals (NASDAQ:ACAD) Price Target Increased to $65.00 by Analysts at Morgan Stanley
americanbankingnews.com - March 3 at 10:22 AM
ACADIA Pharmaceuticals (NASDAQ:ACAD) Stock Price Down 5.3%ACADIA Pharmaceuticals (NASDAQ:ACAD) Stock Price Down 5.3%
americanbankingnews.com - March 2 at 7:02 PM
ACADIA Pharmaceuticals (NASDAQ:ACAD) PT Raised to $63.00ACADIA Pharmaceuticals (NASDAQ:ACAD) PT Raised to $63.00
americanbankingnews.com - March 2 at 10:02 AM
Equities Analysts Offer Predictions for ACADIA Pharmaceuticals Inc.s Q1 2021 Earnings (NASDAQ:ACAD)Equities Analysts Offer Predictions for ACADIA Pharmaceuticals Inc.'s Q1 2021 Earnings (NASDAQ:ACAD)
americanbankingnews.com - March 1 at 2:28 AM
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Expected to Post Q1 2021 Earnings of ($0.58) Per ShareACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Expected to Post Q1 2021 Earnings of ($0.58) Per Share
americanbankingnews.com - March 1 at 2:28 AM
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Just Released Its Full-Year Results And Analysts Are Updating Their EstimatesACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Just Released Its Full-Year Results And Analysts Are Updating Their Estimates
nasdaq.com - March 1 at 1:06 AM
Morgan Stanley Maintains Overweight on ACADIA Pharmaceuticals, Raises Price Target to $65Morgan Stanley Maintains Overweight on ACADIA Pharmaceuticals, Raises Price Target to $65
benzinga.com - February 26 at 10:23 AM
ACADIA Pharmaceuticals shares are trading lower after the company reported worse-than-expected Q4 sales results.ACADIA Pharmaceuticals shares are trading lower after the company reported worse-than-expected Q4 sales results.
benzinga.com - February 26 at 10:23 AM
ACADIA Pharmaceuticals (ACAD) "Overweight" Rating Reaffirmed at Morgan StanleyACADIA Pharmaceuticals' (ACAD) "Overweight" Rating Reaffirmed at Morgan Stanley
americanbankingnews.com - February 25 at 10:09 AM
ACADIA Pharmaceuticals Inc. 2020 Q4 - Results - Earnings Call PresentationACADIA Pharmaceuticals Inc. 2020 Q4 - Results - Earnings Call Presentation
seekingalpha.com - February 25 at 4:10 AM
ACADIA Pharmaceuticals (NASDAQ:ACAD) Receives "Buy" Rating from MizuhoACADIA Pharmaceuticals (NASDAQ:ACAD) Receives "Buy" Rating from Mizuho
americanbankingnews.com - February 25 at 1:02 AM
Acadia Pharmaceuticals (ACAD) Reports Q4 Loss, Lags Revenue EstimatesAcadia Pharmaceuticals (ACAD) Reports Q4 Loss, Lags Revenue Estimates
nasdaq.com - February 24 at 8:18 PM
Acadia Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial ResultsAcadia Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results
finance.yahoo.com - February 24 at 8:18 PM
Recap: ACADIA Pharmaceuticals Q4 EarningsRecap: ACADIA Pharmaceuticals Q4 Earnings
finance.yahoo.com - February 24 at 8:18 PM
Glaucoma Pharmaceuticals Market Recent Trends, In-depth Analysis, Market Size Research Report Forecast up to 2025Glaucoma Pharmaceuticals Market Recent Trends, In-depth Analysis, Market Size Research Report Forecast up to 2025
marketwatch.com - February 23 at 10:35 PM
A Preview Of ACADIA Pharmaceuticalss EarningsA Preview Of ACADIA Pharmaceuticals's Earnings
benzinga.com - February 23 at 12:33 PM
Announcing: ACADIA Pharmaceuticals (NASDAQ:ACAD) Stock Increased An Energizing 191% In The Last Five YearsAnnouncing: ACADIA Pharmaceuticals (NASDAQ:ACAD) Stock Increased An Energizing 191% In The Last Five Years
finance.yahoo.com - February 23 at 7:33 AM
Acadia Pharmaceuticals Recognizes National Caregiver’s Day with Launch of MoreThanMemoryLoss.comAcadia Pharmaceuticals Recognizes National Caregiver’s Day with Launch of MoreThanMemoryLoss.com
finance.yahoo.com - February 19 at 12:31 PM
Interesting ACAD Put And Call Options For April 1stInteresting ACAD Put And Call Options For April 1st
nasdaq.com - February 11 at 6:27 PM
Trade Alert: The CEO & Director Of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), Stephen Davis, Has Sold Some Shares RecentlyTrade Alert: The CEO & Director Of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), Stephen Davis, Has Sold Some Shares Recently
nasdaq.com - February 10 at 7:59 AM
Glaucoma Pharmaceuticals Market Analysis, Trends, Growth, Size, Share and Forecast 2019 to 2025Glaucoma Pharmaceuticals Market Analysis, Trends, Growth, Size, Share and Forecast 2019 to 2025
marketwatch.com - February 9 at 8:19 AM
Glaucoma Pharmaceuticals Market Size By Regional Industry Growth, Statistics And ForecastGlaucoma Pharmaceuticals Market Size By Regional Industry Growth, Statistics And Forecast
marketwatch.com - February 1 at 1:42 PM
Acadia Pharmaceuticals Announces Commercial Leadership ChangeAcadia Pharmaceuticals Announces Commercial Leadership Change
finance.yahoo.com - January 27 at 6:07 PM
Interesting ACAD Put And Call Options For April 16thInteresting ACAD Put And Call Options For April 16th
nasdaq.com - January 6 at 1:40 PM
Interesting ACAD Put And Call Options For February 2021Interesting ACAD Put And Call Options For February 2021
nasdaq.com - December 18 at 1:18 PM
Mizuho Initiates Coverage On ACADIA Pharmaceuticals with Buy Rating, Announces Price Target of $69Mizuho Initiates Coverage On ACADIA Pharmaceuticals with Buy Rating, Announces Price Target of $69
benzinga.com - December 17 at 7:35 PM
Morgan Stanley Maintains Overweight on ACADIA Pharmaceuticals, Raises Price Target to $60Morgan Stanley Maintains Overweight on ACADIA Pharmaceuticals, Raises Price Target to $60
benzinga.com - December 17 at 7:35 PM
Is ACAD A Good Stock To Buy Now?Is ACAD A Good Stock To Buy Now?
finance.yahoo.com - December 15 at 3:02 PM
Glaucoma Pharmaceuticals Market Research Analysis and Competitive Analysis 2020 to 2025 With Impact of Covid-19Glaucoma Pharmaceuticals Market Research Analysis and Competitive Analysis 2020 to 2025 With Impact of Covid-19
marketwatch.com - December 9 at 7:28 AM
Why Is Acadia (ACAD) Up 9.7% Since Last Earnings Report?Why Is Acadia (ACAD) Up 9.7% Since Last Earnings Report?
finance.yahoo.com - December 4 at 4:29 PM
ACADIA Pharmaceuticals Inc.s (NASDAQ:ACAD) Shift From Loss To ProfitACADIA Pharmaceuticals Inc.'s (NASDAQ:ACAD) Shift From Loss To Profit
finance.yahoo.com - November 25 at 7:15 AM
Parkinsons Dyskinesia Market Size Report 2020 Global Industry Analysis by Trends, Revenue, Share, Revenue and Forecast to 2025Parkinson's Dyskinesia Market Size Report 2020 Global Industry Analysis by Trends, Revenue, Share, Revenue and Forecast to 2025
marketwatch.com - November 21 at 2:40 PM
Glaucoma Pharmaceuticals Market Analysis, Innovation Trends and Current Business Trends by 2025Glaucoma Pharmaceuticals Market Analysis, Innovation Trends and Current Business Trends by 2025
marketwatch.com - November 20 at 6:39 PM
ACADIA Pharmaceuticals Inc.s (ACAD) CEO Stephen Davis at 2020 Stifel Virtual Healthcare Conference (Transcript)ACADIA Pharmaceuticals Inc.'s (ACAD) CEO Stephen Davis at 2020 Stifel Virtual Healthcare Conference (Transcript)
seekingalpha.com - November 18 at 6:23 PM
Alzheimer’s Therapeutic Market 2020 Trends, Key Players, Manufacturers Data, Price Analysis, Company Profiling By Type, By Density CompositionAlzheimer’s Therapeutic Market 2020 Trends, Key Players, Manufacturers Data, Price Analysis, Company Profiling By Type, By Density Composition
marketwatch.com - November 10 at 3:52 AM
What's Behind Acadia Pharmaceuticals' Mixed Q3 ResultsWhat's Behind Acadia Pharmaceuticals' Mixed Q3 Results
finance.yahoo.com - November 5 at 1:12 PM
ACADIA Pharmaceuticals Inc.s (ACAD) CEO Steve Davis on Q3 2020 Results - Earnings Call TranscriptACADIA Pharmaceuticals Inc.'s (ACAD) CEO Steve Davis on Q3 2020 Results - Earnings Call Transcript
seekingalpha.com - November 5 at 12:30 AM
Acadia Pharmaceuticals Reports Third Quarter 2020 Financial ResultsAcadia Pharmaceuticals Reports Third Quarter 2020 Financial Results
finance.yahoo.com - November 4 at 7:29 PM
Acadia Pharmaceuticals (ACAD) Reports Q3 Loss, Tops Revenue EstimatesAcadia Pharmaceuticals (ACAD) Reports Q3 Loss, Tops Revenue Estimates
finance.yahoo.com - November 4 at 7:29 PM
Acadia Pharmaceuticals to Present New Scientific Data on Pimavanserin in Neurodegenerative Diseases at the 13th Clinical TrialsAcadia Pharmaceuticals to Present New Scientific Data on Pimavanserin in Neurodegenerative Diseases at the 13th Clinical Trials
bloomberg.com - October 27 at 6:07 AM
Were Hedge Funds Wrong About Embracing ACADIA Pharmaceuticals Inc. (ACAD)?Were Hedge Funds Wrong About Embracing ACADIA Pharmaceuticals Inc. (ACAD)?
finance.yahoo.com - October 26 at 10:34 PM
Acadia PharmaceuticalsAcadia Pharmaceuticals
fool.com - October 24 at 6:27 PM
The Schizophrenia market is expected to increase with a CAGR of 6.89% for the study period 2017-2030 in the 7MM, estimates DelveInsightThe Schizophrenia market is expected to increase with a CAGR of 6.89% for the study period 2017-2030 in the 7MM, estimates DelveInsight
prnewswire.com - October 21 at 2:05 PM
The Lewy Body Dementia Association and Acadia Pharmaceuticals to Release Educational Version of the Highly Acclaimed Robin Williams Documentary, “Robin’s Wish”The Lewy Body Dementia Association and Acadia Pharmaceuticals to Release Educational Version of the Highly Acclaimed Robin Williams Documentary, “Robin’s Wish”
businesswire.com - October 14 at 6:42 PM
Glaucoma Pharmaceuticals Market 2020 Share, Size, Regional Trend, Top Manufacturers, Future Growth, Types and Applications, Forecast to 2026Glaucoma Pharmaceuticals Market 2020 Share, Size, Regional Trend, Top Manufacturers, Future Growth, Types and Applications, Forecast to 2026
marketwatch.com - September 15 at 12:30 PM
ACADIA Pharmaceuticals Inc. (ACAD) CEO Steve Davis Presents at Morgan Stanley 18th Annual Global Healthcare Conference (Transcript)ACADIA Pharmaceuticals Inc. (ACAD) CEO Steve Davis Presents at Morgan Stanley 18th Annual Global Healthcare Conference (Transcript)
seekingalpha.com - September 14 at 8:38 PM
Acadia (ACAD) Down 12% Since Last Earnings Report: Can It Rebound?Acadia (ACAD) Down 12% Since Last Earnings Report: Can It Rebound?
finance.yahoo.com - September 4 at 2:42 PM
ACADIA Pharmaceuticals to Present at Upcoming Investor ConferencesACADIA Pharmaceuticals to Present at Upcoming Investor Conferences
finance.yahoo.com - September 2 at 12:28 PM
This page was last updated on 3/8/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.